Blue Pointe Capital Management, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Blue Pointe Capital Management, LLC
- $154 Billion
- Q3 2024
A detailed history of Blue Pointe Capital Management, LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Blue Pointe Capital Management, LLC holds 10,378 shares of RVPH stock, worth $13,180. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,378
Previous 10,378
-0.0%
Holding current value
$13,180
Previous $13.3 Million
12.5%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding RVPH
# of Institutions
40Shares Held
9.97MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$4.05 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$2.33 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$1.93 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$869,7020.01% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $26M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...